Finally, Sumitomo Mitsui Asset Management Company LTD boosted its position in shares of Teva Pharmaceutical Industries Limited by 11.3% in the first quarter.
Morgan Stanley Income Securities Inc.is a diversified, closed-end management investment company. Hills Bank & Trust Company who had been investing in Teva Pharmaceutical Inds Spons for a number of months, seems to be less bullish one the $16.58 billion market cap company. About shares traded. Ally Financial Inc (NYSE:ALLY) has risen 12.72% since August 28, 2016 and is uptrending. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 27, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.
Frank Brosens decreased its stake in Ally Finl Inc (Call) (ALLY) by 89.09% based on its latest 2016Q4 regulatory filing with the SEC. The hedge fund run by Frank Brosens held 300,000 shares of the consumer services company at the end of 2016Q4, valued at $390,000, down from 2.75 million at the end of the previous reported quarter. The company has market cap of $980.07 million.
Among 27 analysts covering Teva Pharma (NYSE:TEVA), 6 have Buy rating, 3 Sell and 18 Hold. Therefore 33% are positive. BidaskClub downgraded shares of Teva Pharmaceutical Industries Limited from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Buy” rating given on Tuesday, January 31 by Bank of America. The company was maintained on Friday, July 21 by Raymond James. On Wednesday, June 15 the stock rating was initiated by Monness Crespi & Hardt with “Buy”. More interesting news about Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) were released by: Investorplace.com and their article: “Buy the Capitulation in Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock” published on August 17, 2017 as well as Investorplace.com’s news article titled: “Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?” with publication date: August 02, 2017. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Buy” rating by Mizuho on Monday, December 7. TCP Capital had 12 analyst reports since August 7, 2015 according to SRatingsIntel.
Eyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) had an increase of 1.47% in short interest. On Thursday, August 3 the stock rating was maintained by Piper Jaffray with “Hold”. Teva Pharmaceutical Industries Limited has a 12 month low of $15.85 and a 12 month high of $52.66. The dividend payment will be $0.275 per share for the quarter or $1.10 annualized.
Investors sentiment increased to 1.32 in 2016 Q4. Its the same as in 2016Q3. Ameriprise Financial Inc. raised its stake in shares of Teva Pharmaceutical Industries Limited by 142.2% in the first quarter. Vaughan Nelson Investment Mngmt L P, a Texas-based fund reported 2.98 million shares. 1607 Capital Partners Llc owns 783,223 shares or 0.95% of their USA portfolio. Dorsey & Whitney Trust stated it has 154,470 shares. The institutional investor owned 379,348 shares of the company’s stock after selling 245,966 shares during the period. 30,000 shares valued at $713,424 were sold by SUWINSKI JAN on Monday, May 8. Blackrock Ltd Limited Liability Company reported 131,031 shares. Barrett Asset Mgmt Ltd Liability invested in 439,609 shares or 2.26% of the stock. Cambridge Investment Rech Advsrs invested 0% in TCP Capital Corp (NASDAQ:TCPC). Orrstown Financial Serv reported 0.01% stake. Blackrock Gp Ltd holds 0% in ACI Worldwide Inc (NASDAQ:ACIW) or 85,745 shares. Forbes J M Llp accumulated 194,166 shares.
Since March 3, 2017, it had 0 buys, and 1 insider sale for $984,174 activity. It also reduced Brookfield Asset Management Inc.
The company is so far trading down by -0.48 percent from yesterday’s close. Credit Suisse Group downgraded Teva Pharmaceutical Industries Limited from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $25.00 to $13.00 in a report on Wednesday. Therefore 100% are positive. Bemis Company Inc. had 36 analyst reports since September 14, 2015 according to SRatingsIntel. BMO Capital Markets maintained Power Corporation of Canada (TSE:POW) on Friday, June 24 with “Outperform” rating. Citigroup downgraded the shares of BMS in report on Wednesday, April 6 to “Neutral” rating. The rating was downgraded by BMO Capital Markets to “Market Perform” on Thursday, March 31. Maxim Group has “Hold” rating and $3500 target. The stock has “Buy” rating by Mizuho on Thursday, August 25. The firm has “Market Outperform” rating by Avondale given on Friday, February 26. M Partners maintained the shares of MSFT in report on Friday, July 21 with “Hold” rating. The firm earned “Buy” rating on Tuesday, July 25 by UBS.